Evans A E, Simmons R L, Ferris R D, Hasell S K, Letley E, Freestone D S
J Hyg (Lond). 1979 Jun;82(3):489-95. doi: 10.1017/s0022172400054012.
Intranasal vaccination with a single 0.5 ml dose of 10(7.0) EID 50 WRL 105 strain live influenza vaccine elicited four-fold or greater increases in circulating homotypic haemagglutinating inhibiting (HAI) antibody in 60 (64.5%) of 93 volunteers, or in 58 (74.4%) of 78 volunteers with HAI antibody titres before vaccination of less than or equal to 1/20. In comparison, in a group of volunteers vaccinated 9 months previously re-vaccination elicited antibody responses in only 4 (6.9%) of 58 volunteers, or in 3 (14.3%) of 21 volunteers with antibody titres before vaccination of less than or equal to 1/20. Titres of vaccine-induced antibody and antibody resulting from earlier natural infection appeared to fall slowly and at equivalent rates over a 9 month period.
用0.5毫升单剂量含10(7.0) EID 50的WRL 105株活流感疫苗进行鼻内接种,在93名志愿者中有60名(64.5%),或在接种前血凝抑制(HAI)抗体滴度小于或等于1/20的78名志愿者中有58名(74.4%),其循环中的同型HAI抗体增加了四倍或更多。相比之下,在一组9个月前接种过疫苗的志愿者中,再次接种疫苗仅在58名志愿者中的4名(6.9%),或在接种前抗体滴度小于或等于1/20的21名志愿者中的3名(14.3%)引发了抗体反应。疫苗诱导的抗体滴度以及早期自然感染产生的抗体滴度在9个月期间似乎下降缓慢且速率相当。